Dr. Robert S. Benjamin, MD

Dr. Benjamin practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Benjamin's NPI, 1790798676, was assigned on August 14, 2006. Dr. Benjamin graduated from New York University School of Medicine in 1968. Dr. Benjamin holds Texas license E3203.

Dr. Benjamin's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Benjamin's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benjamin practices. Vendor and product names are available with a free account.

Medical oncology is Dr. Benjamin's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Benjamin is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Benjamin's licenses on file in 4 states: Texas, California, Florida and Oklahoma.

Dmand AI lists prostate cancer among the conditions Dr. Benjamin treats.

CMS data shows 107 Medicare services from Dr. Benjamin across 2 procedure codes in 2023, all of them office visits. Medicare paid $7,432 for them. Every service was in a facility, such as a hospital, rather than an office.

Across all payers, Dmand AI patient panel data puts Dr. Benjamin's median patient age at 66, with 58% women.

In 2024, Dr. Benjamin wrote 12 Medicare Part D claims. They cover 2 drugs, with $282,030 in total drug cost. In 2022, CMS named 33 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Benjamin for performance year 2024, reported as part of a group. Dr. Benjamin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Benjamin as offering telehealth.

Dmand AI links 431 papers to Dr. Benjamin, published from 2005 to 2025. 2016 was the busiest year, with 12. The most frequent topics are Sarcoma, Antineoplastic Agents and Doxorubicin. Dr. Benjamin has published most often in Cancer. Dr. Benjamin's most frequent co-authors are Vinod Ravi, MD, Shreyaskumar R. Patel and Dejka M. Araujo, MD.

Dmand AI links Dr. Benjamin to 2 clinical trials. Conditions studied include Sarcoma, Sarcoma, Ewing and Neoplasms, Connective and Soft Tissue. M.D. Anderson Cancer Center sponsors the most, 2.

CMS Open Payments shows 7 general payments to Dr. Benjamin from 3 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $717.

Dmand AI lists 4 awards for Dr. Benjamin, most recently America's Top Doctors in 2014.

Dr. Benjamin graduated from New York University School of Medicine in 1968. Dr. Benjamin is a member of ASCO.

Dr. Benjamin is in network with 3 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 3. Check the plan with the practice before a visit.